Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: A critical review and evaluation of the literature

Journal of Alzheimer's Disease

Volumn 21, Issue 3, 2010, Pages 673-690

  Huang, Tina L ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; cognitive decline; dementia; fish; omega 3 fatty acids

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

AGING; ALZHEIMER DISEASE; BRAIN TISSUE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FISH; HUMAN; NEUROPROTECTION; NUTRIENT; PRIORITY JOURNAL; REVIEW;

EID: 77957258309     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-090934     Document Type: Review

References (145)

1. Older Americans 2008: Key Indicators of Well-being. Federal Interagency Forum on Aging Related Statistics.
2. Alzheimer's Association (2009) 2009 Alzheimer's disease facts and figures. Alzheimers Dementia 5, 234-270.
3. Hebert LE, Beckett LA, Scherr PA, Evans DA (2001) Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 15, 169-173.
4. Lukiw WJ, Bazan NG (2008) Docosahexaenoic acid and the aging brain. J Nutr 138, 2510-2514.
5. Grant W (1997) Dietary links to Alzheimer's disease. Alzheimer's Disease Review 2, 42-55.
6. Graves AB, Rajaram L, Bowen JD, McCormick WC, Mc- Curry SM, Larson EB (1999) Cognitive decline and Japanese culture in a cohort of older Japanese Americans in King County,WA: The Kame Project. J Gerontol B Psychol Sci Soc Sci 54, S154-161. (Pubitemid 29258679)
7. Burr GO, Burr MM(1973) Nutrition classics from The Journal of Biological Chemistry 82:345-67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr Rev 31, 248-249.
8. Holman RT (1998) The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr 128, 427S-433.S.
9. Plourde M, Cunnane SC (2007) Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619-634.
10. Bazinet RP, Douglas H, Cunnane SC (2003) Whole-body utilization of n-3 PUFA in n-6 PUFA-deficient rats. Lipids 38, 187-189. (Pubitemid 36457728)
11. Liou YA, King DJ, Zibrik D, Innis SM (2007) Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 137, 945-952. (Pubitemid 46596892)
12. Contreras MA, Rapoport SI (2002) Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues. Curr Opin Lipidol 13, 267-272.
13. Holman RT (1986) Nutritional and biochemical evidences of acyl interaction with respect to essential polyunsaturated fatty acids. Prog Lipid Res 25, 29-39.
14. Williard DE, Nwankwo JO, Kaduce TL, Harmon SD, Irons M, Moser HW, Raymond GV, Spector AA (2001) Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts. J Lipid Res 42, 501-508. (Pubitemid 32366992)
15. Ikemoto A, Ohishi M, Sato Y, Hata N, Misawa Y, Fujii Y, Okuyama H (2001) Reversibility of n-3 fatty acid deficiencyinduced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid Res 42, 1655-1663. (Pubitemid 33020098)
16. Polozova A, Salem N, Jr. (2007) Role of liver and plasma lipoproteins in selective transport of n-3 fatty acids to tissues: A comparative study of 14C-DHA and 3H-oleic acid tracers. J Mol Neurosci 33, 56-66. (Pubitemid 47574959)
17. Rapoport SI, Chang MC, Spector AA (2001) Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 42, 678-685.
18. Kamp F, Guo W, Souto R, Pilch PF, Corkey BE, Hamilton JA (2003) Rapid flip-flop of oleic acid across the plasma membrane of adipocytes. J Biol Chem 278, 7988-7995. (Pubitemid 36800537)
19. Kamp F, Zakim D, Zhang F, Noy N, Hamilton JA (1995) Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry 34, 11928-11937.
20. Hui TY, Bernlohr DA (1997) Fatty acid transporters in animal cells. Front Biosci 2, d222-231.
21. Herz J (2003) LRP: A bright beacon at the blood-brain barrier. J Clin Invest 112, 1483-1485. (Pubitemid 38056274)
22. Poirier J (2000) Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann N Y Acad Sci 924, 81-90. (Pubitemid 32050187)
23. Beffert U, Stolt PC, Herz J (2004) Functions of lipoprotein receptors in neurons. J Lipid Res 45, 403-409. (Pubitemid 38337986)
24. Hamilton JA, Hillard CJ, Spector AA, Watkins PA (2007) Brain uptake and utilization of fatty acids, lipids and lipoproteins: Application to neurological disorders. J Mol Neurosci 33, 2-11.
25. Plourde M (2009) Does altered omega-3 fatty acid metabolism contribute to cognitive aging? In Handbook of Cognitive Aging: Causes, Processes and Effects, Gariépy Q, Ménard R, Ed. Nova Science Publishers, Hauppauge, N.Y.
26. Freemantle E, Vandal M, Tremblay-Mercier J, Tremblay S, Blachere JC, Begin ME, Brenna JT, Windust A, Cunnane SC (2006) Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 75, 213-220. (Pubitemid 44292526)
27. McCloy U, Ryan MA, Pencharz PB, Ross RJ, Cunnane SC (2004) A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women. J Lipid Res 45, 474-485. (Pubitemid 38337994)
28. Rees D, Miles EA, Banerjee T,Wells SJ, Roynette CE,Wahle KW, Calder PC (2006) Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am J Clin Nutr 83, 331-342. (Pubitemid 44713195)
29. Cole GM, Frautschy SA (2006) Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr Health 18, 249-259.
30. Sakamoto T, Cansev M, Wurtman RJ (2007) Oral supplementation with docosahexaenoic acid and uridine-5'- monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182, 50-59. (Pubitemid 350086992)
31. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N, Jr., Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633-645. (Pubitemid 39179724)
32. He C, Qu X, Cui L, Wang J, Kang JX (2009) Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci U S A 106, 11370-11375.
33. Hooijmans CR, Rutters F, Dederen PJ, Gambarota G, Veltien A, Van Groen T, Broersen LM, Lutjohann D, Heerschap A, Tanila H, Kiliaan AJ (2007) Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol Dis 28, 16-29. (Pubitemid 47432903)
34. Hooijmans CR, Van Der Zee CE, Dederen PJ, Brouwer KM, Reijmer YD, Van Groen T, Broersen LM, Lutjohann D, Heerschap A, Kiliaan AJ (2009) DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis 33, 482-498.
35. Hashimoto M, Hossain S, Agdul H, Shido O (2005) Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergentinsoluble membrane fractions. Biochim Biophys Acta 1738, 91-98. (Pubitemid 43122134)
36. Wolozin B (2001) A fluid connection: Cholesterol and Abeta. Proc Natl Acad Sci U S A 98, 5371-5373.
37. Cole GM, Ma QL, Frautschy SA (2009) Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids 81, 213-221.
38. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko- Mauro KA, Ellis L, LaFerla FM (2007) Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloidbeta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 27, 4385-4395. (Pubitemid 46640724)
39. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N, Jr., Frautschy SA, Cole GM (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25, 3032-3040. (Pubitemid 40463537)
40. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 81, 1084-1091. (Pubitemid 34809291)
41. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O (2005) Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135, 549-555. (Pubitemid 40365217)
42. Yuan YV, Kitts DD (2003) Dietary (n-3) fat and cholesterol alter tissue antioxidant enzymes and susceptibility to oxidation in SHR and WKY rats. J Nutr 133, 679-688.
43. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
44. APA (1994) DSM-IV Diagnostic and Statistic Manual of Mental Disorders, American Psychiatric Association, Washington, D.C.
45. Petersen RC, Smith GE,Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
46. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR (2007) Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The Atherosclerosis Risk in Communities Study. Am J Clin Nutr 85, 1103-1111. (Pubitemid 46557928)
47. Beydoun MA, Kaufman JS, Sloane PD, Heiss G, Ibrahim J (2008) n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study. Public Health Nutr 11, 17-29. (Pubitemid 350233687)
48. Heude B, Ducimetiere P, Berr C (2003) Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr 77, 803-808.
49. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D (1997) Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 145, 33-41. (Pubitemid 27009055)
50. Dullemeijer C, Durga J, Brouwer IA, Van De Rest O, Kok FJ, Brummer RJ, Van Boxtel MP, Verhoef P (2007) n 3 fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr 86, 1479-1485. (Pubitemid 350126254)
51. Van Gelder BM, Tijhuis M, Kalmijn S, Kromhout D (2007) Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: The Zutphen Elderly Study. Am J Clin Nutr 85, 1142-1147. (Pubitemid 46557933)
52. Morris MC, Evans DA, Tangney CC, Bienias JL,Wilson RS (2005) Fish consumption and cognitive decline with age in a large community study. Arch Neurol 62, 1849-1853. (Pubitemid 41785078)
53. Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC (2008) n-3 Fatty acid erythrocyte membrane content, APOE epsilon4 and cognitive variation: An observational follow-up study in late adulthood. Am J Clin Nutr 87, 449-454.
54. Eskelinen MH, Ngandu T, Helkala EL, Tuomilehto J, Nissinen A, Soininen H, Kivipelto M (2008) Fat intake at midlife and cognitive impairment later in life: A population-based CAIDE study. Int J Geriatr Psychiatry 23, 741-747.
55. Crane PK, Narasimhalu K, Gibbons LE, Mungas DM, Haneuse S, Larson EB, Kuller L, Hall K, Van Belle G (2008) Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol 61, 1018-1027 e1019.
56. Ashford JW (2008) Screening for memory disorders, dementia and Alzheimer's disease. Aging Health 4, 339.
57. Ashford JW, Schmitt FA (2001) Modeling the time-course of Alzheimer dementia. Curr Psychiatry Rep 3, 20-28.
58. Barberger-Gateau P, Jutand MA, Letenneur L, Larrieu S, Tavernier B, Berr C (2005) Correlates of regular fish consumption in French elderly community dwellers: Data from the Three-City study. Eur J Clin Nutr 59, 817-825. (Pubitemid 41029457)
59. Cherubini A, Andres-Lacueva C, Martin A, Lauretani F, Iorio AD, Bartali B, Corsi A, Bandinelli S, Mattson MP, Ferrucci L (2007) Low plasma N-3 fatty acids and dementia in older persons: The InCHIANTI study. J Gerontol A Biol Sci Med Sci 62, 1120-1126. (Pubitemid 47599423)
60. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH (2000) Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35, 1305-1312. (Pubitemid 32064179)
61. Kalmijn S, Van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ (2004) Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62, 275-280. (Pubitemid 38167138)
62. Manzato E, Roselli della Rovere G, Zambon S, Romanato G, Corti MC, Sartori L, Baggio G, Crepaldi G (2003) Cognitive functions are not affected by dietary fatty acids in elderly subjects in the Pro.V.A. study population. Aging Clin Exp Res 15, 83-86. (Pubitemid 36675442)
63. Nurk E, Drevon CA, Refsum H, Solvoll K, Vollset SE, Nygard O, Nygaard HA, Engedal K, Tell GS, Smith AD (2007) Cognitive performance among the elderly and dietary fish intake: The Hordaland Health Study. Am J Clin Nutr 86, 1470-1478. (Pubitemid 350126253)
64. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ (2003) Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: A case-control study. Br J Nutr 89, 483-489. (Pubitemid 36582118)
65. Wang W, Shinto L, Connor WE, Quinn JF (2008) Nutritional biomarkers in Alzheimer's disease: The association between carotenoids, n-3 fatty acids, and dementia severity. J Alzheimers Dis 13, 31-38. (Pubitemid 351365625)
66. Whalley LJ, Fox HC, Wahle KW, Starr JM, Deary IJ (2004) Cognitive aging, childhood intelligence, and the use of food supplements: Possible involvement of n-3 fatty acids. Am J Clin Nutr 80, 1650-1657.
67. Albanese E, Dangour AD, Uauy R, Acosta D, Guerra M, Guerra SS, Huang Y, Jacob KS, De Rodriguez JL, Noriega LH, Salas A, Sosa AL, Sousa RM, Williams J, Ferri CP, Prince MJ (2009) Dietary fish and meat intake and dementia in Latin America, China, and India: A 10/66 Dementia Research Group population-based study. Am J Clin Nutr 90, 392-400.
68. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S (2002) Fish, meat, and risk of dementia: Cohort study. BMJ 325, 932-933. (Pubitemid 35265208)
69. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alperovitch A (2007) Dietary patterns and risk of dementia: The Three-City cohort study. Neurology 69, 1921-1930. (Pubitemid 350100350)
70. Devore EE, Grodstein F, Van Rooij FJ, Hofman A, Rosner B, Stampfer MJ, Witteman JC, Breteler MM (2009) Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 90, 170-176.
71. Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, Burke GL, Carlson MC (2005) Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 65, 1409-1414.
72. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, BretelerMM(1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42, 776-782. (Pubitemid 27481550)
73. Morris MC, EvansDA, Bienias JL, Tangney CC, BennettDA, Wilson RS, Aggarwal N, Schneider J (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60, 940-946. (Pubitemid 36858352)
74. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA (2006) Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol 63, 1545-1550. (Pubitemid 44748796)
75. Jia T-d, Kelleher SD, Hultin HO, Petillo D, Maney R, Krzynowek J (1996) Comparison of quality loss and changes in the glutathione antioxidant system in stored mackerel and bluefish muscle. J Agric Food Chem 44, 1195-1201. (Pubitemid 126467843)
76. Passi S, Cataudella S, Tiano L, Littarru GP (2005) Dynamics of lipid oxidation and antioxidant depletion in Mediterranean fish stored at different temperatures. Biofactors 25, 241-254. (Pubitemid 44070856)
77. Petillo D, Hultin HO, Krzynowek J, Autio WR (1998) Kinetics of antioxidant loss in mackerel light and dark muscle. J Agric Food Chem 46, 4128-4137. (Pubitemid 128488504)
78. Candela M, Astiasaran I, Bello J (1998) Deep-fat frying modifies high-fat fish lipid fraction. J Agric Food Chem y 46, 2793-2796. (Pubitemid 128488373)
79. Echarte M, Zulet MA, Astiasaran I (2001) Oxidation process affecting fatty acids and cholesterol in fried and roasted salmon. J Agric Food Chem 49, 5662-5667. (Pubitemid 33089722)
80. Regulska-llow B, Ilow R (2002) Comparison of the effects of microwave cooking and conventional cooking methods on the composition of fatty acids and fat quality indicators in herring. Nahrung 46, 383-388. (Pubitemid 135742454)
81. Song JH, Fujimoto K, Miyazawa T (2000) Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acidcontaining oils. J Nutr 130, 3028-3033. (Pubitemid 32005334)
82. Grant WB (2009) Does vitamin D reduce the risk of dementia? J Alzheimers Dis 17, 151-159.
83. Ouellet V, Marois J,Weisnagel SJ, Jacques H (2007) Dietary cod protein improves insulin sensitivity in insulin-resistant men and women: A randomized controlled trial. Diabetes Care 30, 2816-2821. (Pubitemid 350083125)
84. Zhou D, Ghebremeskel K, Crawford MA, Reifen R (2006) Vitamin A deficiency enhances docosahexaenoic and osbond acids in liver of rats fed an alpha linolenic acid-adequate diet. Lipids 41, 213-219.
85. Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17, 525-530. (Pubitemid 124000830)
86. Gong JS,Kobayashi M, Hayashi H, Zou K, Sawamura N, Fujita SC, Yanagisawa K, Michikawa M(2002) Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem 277, 29919-29926.
87. Pedersen WA, Chan SL, Mattson MP (2000) A mechanism for the neuroprotective effect of apolipoprotein E: Isoformspecific modification by the lipid peroxidation product 4- hydroxynonenal. J Neurochem 74, 1426-1433.
88. Plourde M, Vohl MC, Vandal M, Couture P, Lemieux S, Cunnane SC (2009) Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men. Br J Nutr 102, 1121-1124.
89. Olano-Martin E, Anil E, Caslake MJ, Packard CJ, Bedford D, Stewart G, Peiris D, Williams CM, Minihane AM (2009) Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 209, 104-110.
90. Duara R, Barker WW, Lopez-Alberola R, Loewenstein DA, Grau LB, Gilchrist D, Sevush S, St George-Hyslop S (1996) Alzheimer's disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 46, 1575-1579. (Pubitemid 26185774)
91. Meyer MR, Tschanz JT, Norton MC, Welsh-Bohmer KA, Steffens DC, Wyse BW, Breitner JC (1998) APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease. Nat Genet 19, 321-322.
92. Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47, 387-400. (Pubitemid 26138899)
93. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, Chun M, Tycko B, Shelanski M (1995) Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease
94. [see comments]. Neurology 45, 555-557.
95. Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 33, 494-501. (Pubitemid 23143033)
96. Mayeux R (1998) Gene-environment interaction in lateonset Alzheimer disease: The role of apolipoprotein-epsilon4. Alzheimer Dis Assoc Disord 12 Suppl 3, S10-15.
97. Cedazo-Minguez A, Cowburn RF (2001) Apolipoprotein E: A major piece in the Alzheimer's disease puzzle. J Cell Mol Med 5, 254-266. (Pubitemid 33773001)
98. Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25, 641-650. (Pubitemid 38686487)
99. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90, 9649-9653. (Pubitemid 23315843)
100. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoformspecific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90, 8098-8102. (Pubitemid 23260862)
101. Buttini M,Yu GQ, Shockley K, Huang Y, Jones B, Masliah E, Mallory M, Yeo T, Longo FM, Mucke L (2002) Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. J Neurosci 22, 10539-10548. (Pubitemid 36005128)
102. Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females. Proc Natl Acad Sci U S A 95, 10914-10919. (Pubitemid 28413168)
103. Raber J, Wong D, Yu GQ, Buttini M, Mahley RW, Pitas RE, Mucke L (2000) Apolipoprotein E and cognitive performance. Nature 404, 352-354. (Pubitemid 30164327)
104. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S,Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 97, 6037-6042. (Pubitemid 30367519)
105. Nagy Z, EsiriMM,Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD (1995) Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 69, 757-761.
106. Lanz TA, Carter DB, Merchant KM (2003) Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13, 246-253.
107. Oken E, Radesky JS, Wright RO, Bellinger DC, Amarasiriwardena CJ, Kleinman KP, Hu H, Gillman MW (2008) Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol 167, 1171-1181. (Pubitemid 351670639)
108. Kroger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D (2009) Omega-3 fatty acids and risk of dementia: The Canadian Study of Health and Aging. Am J Clin Nutr 90, 184-192.
109. Jacobson JL, Jacobson SW (1996) Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 335, 783-789.
110. Jacobson JL, Jacobson SW (2002) Association of prenatal exposure to an environmental contaminant with intellectual function in childhood. J Toxicol Clin Toxicol 40, 467-475.
111. Jacobson JL, Jacobson SW(2003) Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr 143, 780-788.
112. Schantz SL, Gasior DM, Polverejan E, McCaffrey RJ, Sweeney AM, Humphrey HE, Gardiner JC (2001) Impairments of memory and learning in older adults exposed to polychlorinated biphenyls via consumption of Great Lakes fish. Environ Health Perspect 109, 605-611. (Pubitemid 32998773)
113. (1999) U.S. Environmental Protection Agency Fact sheet: Polycholorinated Biphenyls (PCBs) Update: Impact on Fish Advisories, Office of Water.
114. Chiu A, Beaubier J, Chiu J, Chan L, Gerstenberger S (2004) Epidemiologic studies of PCB congener profiles in North American fish consuming populations. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 22, 13-36. (Pubitemid 38802822)
115. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A,Witteman JC, Breteler MM(2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287, 3223-3229. (Pubitemid 34686103)
116. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology 59, 1915-1921. (Pubitemid 36076564)
117. Arsenault LN, Matthan N, Scott TM, Dallal G, Lichtenstein AH, Folstein MF, Rosenberg I, Tucker KL (2009) Validity of estimated dietary eicosapentaenoic acid and docosahex aenoic acid intakes determined by interviewer-administered food frequency questionnaire among older adults with mildto- moderate cognitive impairment or dementia. Am J Epidemiol 170, 95-103.
118. Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA (2007) Incident dementia in women is preceded by weight loss by at least a decade. Neurology 69, 739-746.
119. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC (1999) Dietary fat and coronary heart disease: A comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149, 531-540. (Pubitemid 29130020)
120. Kyle DJ, Schaefer E, Patton G, Beiser A (1999) Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia. Lipids 34, S245. (Pubitemid 29323210)
121. Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ (2003) Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 5, 315-322. (Pubitemid 37411779)
122. Samieri C, Feart C, Letenneur L, Dartigues JF, Peres K, Auriacombe S, Peuchant E, Delcourt C, Barberger-Gateau P (2008) Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 88, 714-721.
123. Arab L, Akbar J (2002) Biomarkers and the measurement of fatty acids. Public Health Nutr 5, 865-871.
124. Kohlmeier L, Bellach B (1995) Exposure assessment error and its handling in nutritional epidemiology. Annu Rev Public Health 16, 43-59.
125. Arterburn LM, Hall EB, Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 1467S-1476.S. (Pubitemid 44713087)
126. Brooksbank BW, Martinez M (1989) Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease. Mol Chem Neuropathol 11, 157-185. (Pubitemid 20322834)
127. Corrigan FM, Horrobin DF, Skinner ER, Besson JA, Cooper MB (1998) Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol 30, 197-207.
128. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115, 2774-2783. (Pubitemid 41434404)
129. Nakada T, Kwee IL, Ellis WG (1990) Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease. Neuroreport 1, 153-155.
130. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23, 81-88. (Pubitemid 28145695)
131. Skinner ER,Watt C, Besson JA, Best PV (1993) Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 116, 717-725. (Pubitemid 23203646)
132. Soderberg M, Edlund C, Kristensson K, Dallner G (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26, 421-425.
133. Breckenridge WC, Morgan IG, Zanetta JP, Vincendon G (1973) Adult rat brain synaptic vesicles. II. Lipid composition. Biochim Biophys Acta 320, 681-686.
134. Calon F, Cole G (2007) Neuroprotective action of omega- 3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 77, 287-293. (Pubitemid 350198857)
135. Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10, 136-141. (Pubitemid 46220304)
136. Boston PF, Bennett A, Horrobin DF, Bennett CN (2004) Ethyl-EPA in Alzheimer's disease - a pilot study. Prostaglandins Leukot Essent Fatty Acids 71, 341-346. (Pubitemid 39233559)
137. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32, 1538-1544.
138. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Arch Neurol 63, 1402-1408. (Pubitemid 44547551)
139. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM (2008) Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 11, 75-83.
140. Kotani S, Sakaguchi E,Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56, 159-164. (Pubitemid 44374788)
141. Suzuki H, Morikawa Y, Takahashi H (2001) Effect of DHA oil supplementation on intelligence and visual acuity in the elderly. World Rev Nutr Diet 88, 68-71. (Pubitemid 33210316)
142. Van De Rest O, Geleijnse JM, Kok FJ, Van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, De Groot CP (2008) Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology 71, 430-438.
143. Yehuda S, Rabinovtz S, Carasso RL, Mostofsky DI (1996) Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci 87, 141-149. (Pubitemid 27111507)
144. Einstein GO, Smith RE, McDanielMA,ShawP (1997) Aging and prospective memory: The influence of increased task demands at encoding and retrieval. Psychol Aging 12, 479-488. (Pubitemid 27410176)
145. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I (1997) Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349, 1793-1796. (Pubitemid 27257555)